Robert Stringer has more than 25 years of experience in the Australian and New Zealand pharmaceutical industry.
Prior to establishing Capital K Consulting, Robert was a member of the leadership team at AstraZeneca Australia, having managed the Regulatory Affairs, Clinical Research and Strategic Planning & Business Development teams. His career also includes the green fields market entry into Australia of Sandoz (the generic arm of Novartis), ultimately holding the role of Research and Development Manager. In this role his responsibilities included leading the regulatory, product development, and quality assurance functions, along with joint leadership of the product sourcing and partnering arrangements. At Sandoz, Robert achieved the world-first market approval of a biosimilar.
Robert is an active supporter of the industry. His deep engagement with professional associations includes the provision of pharmaceutical training programs to Australian Association of Regulatory and Clinical Scientists and participation in the Regulatory Affairs Professionals Association (RAPS).
Subscribe to our Newsletter
Want to hear the latest industry news as it happens? Simply fill out the form below and we'll send you regular updates so you can stay in the loop.